Research Projects & Grants

  • Assessment of Central and Peripheral Tissue Responses to Graded Thyroxine Dosing Utilizing the Immunochemiluminometric Assay (ICMA) for TSH, Role: PI, (02/1994 - 01/1995) Status: Completed

Federal

  • Palmitic Acid Regulation of Dendritic Cell Toll-Like Receptor 4 Signaling, Role: Committee Member, National Institutes of Health/DHHS, (09/2013 - 09/2015) Status: Closed
  • LLU Center for Health Disparities Research, Role: Consultant, National Institute of Minority Health and Health Disparities/NIH/NIMHD, (07/2012 - 01/2020) Status: Closed
  • Externally Applied Vibration to Treat Diabetic Ulcers, Role: Co-investigator, National Medical Technology Testbed, Inc., (02/2009 - 03/2011) Status: Closed

For Profit Organization

  • A randomized, double-blind study to compare the durability of glucose lowering and preservation of pancreatic beta-cell function of rosiglitazone monotherapy compared to metformin or glyburide/glibenclamide in patients with drug-naive, recently diagnosed type 2 diabetes mellitus equals to or less than 2 years, Role: PI, Smithkline Beecham, (01/2006 - 01/2007) Status: Completed
  • Target glycemic control and the incidence of symptomatic noctural hypoglycemia in insulin subjects with type 2 diabetes on oral hypoglycemic agent(s) and treated with insulin glargine or NPH human insulin, Role: PI, Hoechst Marion Roussel, Inc., (10/2000 - 10/2001) Status: Completed
  • A double-blind randomized, placebo controlled, multicenter, dose-titration study to assess the safety of twice daily dose regimens of an oral calcimimetic agent (AMG073) in primary hyperparathyroidism, Role: PI, Amgen, Inc., (09/2000 - 09/2001) Status: Completed
  • A double-blind, randomized, placebo-controlled, multicenter study to assess the safety, tolerability, and clinical effects of twice-daily doses of an oral calcimimetic agent in subjects with primary hyperparathyroidism, Role: PI, Amgen, Inc., (06/2000 - 06/2001) Status: Completed
  • A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of a continuous-combined HRT preparation containing 1mg estradiol and 3 mg drospirenone on blood pressure in mildly hypertensive postmenopausal women (protocol 305140), Role: Investigator, Berlex Laboratories Inc., Status: Completed

Internal

  • The effect of vibration on skin blood flow, skin temperature, and blood pressure in good controlled versus poor controlled type 2 diabetes mellitus, Role: Investigator, LLU - GRASP, (08/2012 - 08/2013) Status: Completed
  • Adrenal neoplasm-diagnosis and treatment, Role: PI, LLU Dept. of Medicine, (02/2012 - 02/2013) Status: Completed